STAT Plus: Prime Medicine shrinks CRISPR ambitions and gets cash infusion from Bristol Myers Squibb
CRISPR
CRISPR is a gene editing technology that allows scientists to make precise changes to DNA. Here you can learn about the companies developing CRISPR-based treatments, and the tremendous potential in its use.
For the latest CRISPR advances, check out STAT’s searchable CRISPR Trackr.
Latest
STAT Plus: Vertex, U.K. reach deal to provide CRISPR-based medicine to thalassemia patients in England
STAT Plus: The race to build better CRISPR delivery vehicles is heating up
STAT Plus: Jiankui He, creator of CRISPR-edited children, relocates to a Chinese medical tourism hub
STAT Plus: Trying to outrun her prion disease, researcher creates powerful epigenetic editor in mice
STAT Plus: Intellia’s CRISPR-based treatment dramatically reduced patients’ swelling attacks in small trial
STAT Plus: ChatGPT for genomes: introducing a CRISPR-designing generative AI
STAT Plus: First recipient of kidney transplant from genetically engineered pig has died, family says
All Coverage
advertisement
